TWi Biotechnology, Inc. (6610.TWO)

TWD 13.9

(-4.14%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - 66.39 Million 1.24 Million 9.66 Million
Cost of Revenue 9.73 Million - 913 Thousand 1.04 Million 7.3 Million
Gross Profit -9.73 Million - 65.48 Million 203 Thousand 2.35 Million
Operating Expenses 169.55 Million 90.17 Million 80.78 Million 98.76 Million 117.52 Million
Selling, General and Administrative Expenses 21.15 Million 15.61 Million 14.12 Million 13.77 Million 19.29 Million
Research and Development Expenses 148.4 Million 74.55 Million 66.66 Million 84.98 Million 97 Million
Other Expenses -3.87 Million 12.37 Million -1.31 Million -5.4 Million -
Cost and Expenses 169.55 Million 90.17 Million 81.69 Million 99.8 Million 124.82 Million
Operating Income -169.55 Million -76.12 Million -15.21 Million -100.48 Million -113.94 Million
Interest Expense 87 Thousand 48 Thousand 86 Thousand 20 Thousand 68 Thousand
Income Tax Expense - - - 1.35 Million -
Earnings before Tax -170.68 Million -76.17 Million -15.29 Million -100.5 Million -111.52 Million
Net Income -170.68 Million -76.17 Million -15.29 Million -101.85 Million -111.52 Million
Earnings Per Share Basic -2.33 -1.13 -0.22 -1.45 -1.59
Earnings Per Share Diluted -2.33 -1.13 -0.22 -1.45 -1.59
Weighted Average Shares Outstanding 73.17 Million 67.43 Million 70.22 Million 70.22 Million 70.22 Million
Weighted Average Shares Outstanding (Diluted) 73.17 Million 67.43 Million 70.22 Million 70.22 Million 70.22 Million
Gross Margin - - 0.99 0.16 0.24
EBIT Margin - - -0.06 -71.28 -10.97
Profit Margin - - -0.23 -81.75 -11.54
EBITDA -160.85 Million -65.77 Million -4.11 Million -88.81 Million -100.47 Million
Earnings Before Tax Margin - - -0.23 -80.65 -11.79

Income Statement Charts